Citation Impact
Citing Papers
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
2020 StandoutScience
In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs
2008
Adverse effects of Hif1a mutation and maternal diabetes on the offspring heart
2018
Thrombin Receptors on Human Platelets
1997
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes
2011
Functional Implication of Secretory Proteases Derived from Microglia in the Central Nervous System.
1996
AGEs and Diabetic Retinopathy
2010
Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster
2013
Acute kidney injury
2012 Standout
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Evidence that fibroblasts derive from epithelium during tissue fibrosis
2002 Standout
High processed meat consumption is a risk factor of type 2 diabetes in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention study
2010
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Cultured rat glomerular epithelial cells show gene expression and production of transforming growth factor‐β: expression is enhanced by thrombin
2001
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Mouse Models of Diabetic Nephropathy
2004
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
2016 Standout
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
2008
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Murine Models of Renal Disease: Possibilities and Problems in Studies Using Mutant Mice
2000
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
2007
Quantitative gene expression analysis in renal biopsies: A novel protocol for a high-throughput multicenter application
2002
Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus
2000
Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein, Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic Kidneys
2001
Inflammation and insulin resistance
2006 Standout
The AGE‐receptor in the pathogenesis of diabetic complications
2001
Chronic kidney disease
2011 Standout
Thrombin signalling and protease-activated receptors
2000 StandoutNature
Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?
2010
Pathologies Involving the S100 Proteins and Rage
2007
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2
2004 StandoutNobel
AGE restriction in diabetes mellitus: a paradigm shift
2011
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
2008 StandoutNobel
Role of oxidants and proteases in glomerular injury
1994
Neurodegeneration and Inflammation
2008
A New Perspective on Therapeutic Inhibition of Advanced Glycation in Diabetic Microvascular Complications: Common Downstream Endpoints Achieved Through Disparate Therapeutic Approaches?
2009
In Vitro anti-proliferative and anti-invasive role of aminoterminal fragment of urokinase-type plasminogen activator on 8701-BC breast cancer cells
1996
The microenvironment of the tumour–host interface
2001 StandoutNature
Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro
1999
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
2003 StandoutNature
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Glucose, glycation and aging
2004
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Mitogenic Signaling via G Protein-Coupled Receptors
1996 StandoutNobel
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Ras-dependent Mitogen-activated Protein Kinase Activation by G Protein-coupled Receptors
1997 StandoutNobel
Endometriosis
2010 Standout
Differential growth state‐dependent regulation of plasminogen activator inhibitor type‐1 expression in senescent IMR‐90 human diploid fibroblasts
1995
Diabetes and advanced glycation endproducts
2002
Maillard reaction indicators in diets usually consumed by adolescent population
2007
Functional roles of microglia in the brain
1993
Advanced glycoxidation end products in commonly consumed foods
2004
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Mechanisms of Bone Metastasis
2004 Standout
Advanced glycation end-products: a review
2001 Standout
Thrombin Inhibition During Kidney Ischemia-Reperfusion Reduces Chronic Graft Inflammation and Tubular Atrophy
2010
Mouse Models of Diabetic Nephropathy
2009 Nobel
Diets rich in Maillard reaction products affect protein digestibility in adolescent males aged 11–14 y
2006
Frailty in elderly people
2013 Standout
Immunohistochemical Distribution and Quantitative Biochemical Detection of Advanced Glycation End Products in Fetal to Adult Rats and in Rats with Streptozotocin-Induced Diabetes
2001
Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications
2014
Glomerulosclerosis is transmitted by bone marrow–derived mesangial cell progenitors
2001
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Cell Biology of the Glomerular Podocyte
2003 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products
2004
Advanced Glycation End Products
2006 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Thromboxane A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase.
1994
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Advanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes
2002
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Oxidative Stress and Diabetic Complications
2010 Standout
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
2004
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion
1994
Advanced glycation and retinal pathology during diabetes.
2005
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro.
1994
Signal transduction and the u-PA/u-PAR system
1996
Mechanisms of Diabetic Complications
2013 Standout
Understanding RAGE, the receptor for advanced glycation end products
2005
Protease-Activated Receptor 1 Mediates Thrombin-Dependent, Cell-Mediated Renal Inflammation in Crescentic Glomerulonephritis
2000
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain.
1993
Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy
2002
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy
2009
Advanced Glycosylation End Products Up-Regulate Connective Tissue Growth Factor (Insulin-Like Growth Factor-Binding Protein-Related Protein 2) in Human Fibroblasts: A Potential Mechanism for Expansion of Extracellular Matrix in Diabetes Mellitus*
2001
Glomerulosclerosis is transmitted by bone marrow–derived mesangial cell progenitors
2001
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
2004
High Levels of Dietary Advanced Glycation End Products Transform Low-Dersity Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients
2004
Advanced Glycation End Products Are Direct Modulators of β-Cell Function
2011
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
The Urokinase Receptor. Protein Structure and Role in Plasminogen Activation and Cancer Invasion
1995
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Physiology of Microglia
2011 Standout
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
1992
Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2
1996
Works of Cijiang He being referenced
Thrombin regulates components of the fibrinolytic system in human mesangial cells
1990
Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products
2002
Growth factor-like effect of urokinase type plasminogen activator in human renal cells
1991
Thrombin and Phorbol Ester Induce Internalization of Thrombin Receptor of Human Mesangial Cells through Different Pathways
1995
Restriction of Dietary Glycotoxins Reduces Excessive Advanced Glycation End Products in Renal Failure Patients
2003
Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells
1991
Urokinase synthesis and binding by glomerular epithelial cells in culture
1989
Update on HIV-associated nephropathy
2006
Thrombin signal transduction mechanisms in human glomerular epithelial cells
1992
Differential expression of renal AGE-receptor genes in NOD mice: Possible role in nonobese diabetic renal disease
2000
Inflammatory Bowel Disease: MR- and SPECT/CT-based Macrophage Imaging for Monitoring and Evaluating Disease Activity in Experimental Mouse Model—Pilot Study
2014
Pathogenesis of nonimmune glomerulosclerosis: studies in animals and potential applications to humans.
1995
Elevated AGE-Modified ApoB in Sera of Euglycemic, Normolipidemic Patients with Atherosclerosis: Relationship to Tissue AGEs
1997
Presence of Diabetic Complications in Type 1 Diabetic Patients Correlates with Low Expression of Mononuclear Cell AGE-Receptor-1 and Elevated Serum AGE
2001
Constitutive expression and modulation of the functional thrombin receptor in the human kidney.
1995
Oxidative Stress-Inducing Carbonyl Compounds From Common Foods: Novel Mediators of Cellular Dysfunction
2002
Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice
2003
Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy
1997